Building ePRO Studies On-Demand with Artist
ePRO provider Symfo will now offer technology transfer capabilities with its new product Artist. This new product is a user-friendly tool that allows customers to build and deploy their own ePRO studies on demand.
Users have the option to start with Symfo's full-service offering and migrate to Artist when ready, or to begin using it from the very first study. Artist was designed with simplicity in mind to benefit Data Managers, CRAs, and Clinical Assistants. Programming skills are not necessary and a basic knowledge of the MS Office suite is sufficient, according to the company.
Artist may be accessed locally or through an Internet connection. Designers start by defining the general parameters such as name and languages of the study using a configuration panel. The next step is to design each PDA screen with edit checks and logic. Artist offers a drag and drop interface that is intended to make this step straightforward, including importing translations if necessary. Once all designing is completed, users have the ability to test the application in a built-in emulator. The application is then installed on the PDAs and will launch automatically.
Artist is available on a subscription pay-as-you-go basis, either as a stand-alone product or as part of a turn-key bundled package. Visit the company's Web site for more information on this product, www.symfo.com.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
